Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Loes Linsen

Showing results (21-30 of 22) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 22 results.
Frontiers in Immunology|April 10, 2023
Macrophage-infectivity potentiator of <i>Trypanosoma cruzi</i> (TcMIP) is a new pro-type 1 immuno-stimulating protein for neonatal human cells and vaccines in miceMagdalena Radwanska, Frédéric de Lemos Esteves, Loes Linsen, et al.
BMC Public Health|October 27, 2011
Study protocol of KLIMOP: a cohort study on the wellbeing of older cancer patients in Belgium and the NetherlandsLaura Deckx, Doris van Abbema, Katherine Nelissen, et al.
Pageof 3

Showing results (21-30 of 22) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 22 results.
Frontiers in Immunology|April 10, 2023
Macrophage-infectivity potentiator of <i>Trypanosoma cruzi</i> (TcMIP) is a new pro-type 1 immuno-stimulating protein for neonatal human cells and vaccines in miceMagdalena Radwanska, Frédéric de Lemos Esteves, Loes Linsen, et al.
BMC Public Health|October 27, 2011
Study protocol of KLIMOP: a cohort study on the wellbeing of older cancer patients in Belgium and the NetherlandsLaura Deckx, Doris van Abbema, Katherine Nelissen, et al.
Pageof 3